Foluso Ademuyiwa

Professor at Pediatrics, Washington University in St Louis0 Followers

Dr. Foluso Ademuyiwa excels in the field of oncology, serving as a Professor of Medicine at Washington University School of Medicine. With a dedicated focus on breast neoplasms, Dr. Ademuyiwa's research is particularly centered on triple-negative breast neoplasms, a challenging subtype of breast cancer. His work is pivotal in advancing the understanding and treatment of this aggressive cancer type. Dr. Ademuyiwa employs innovative approaches in his research, utilizing drug therapy and circulating tumor DNA to explore new avenues for treatment. His studies also incorporate estrogen receptor analysis, aiming to uncover insights that could lead to more effective therapeutic strategies. Through his work, Dr. Ademuyiwa contributes significantly to the field of oncology, striving to improve outcomes for patients with breast cancer.

Research Interests

Breast neoplasms Triple-negative breast neoplasms Drug therapy Circulating tumor DNA Estrogen receptor analysis

Publications

1 - Abstract PS2-18: Circulating tumor DNA (ctDNA) mutation (mut) profile in relation to paboclicib (pal) efficacy in hormone receptor positive (HR+) and HER2 negative (HER2-) metastatic breast cancer (MBC),Cancer Research

Jing Xi , Nusayba Bagegni , Foluso Ademuyiwa , Ashley Frith , Rama Suresh , Anna Roshal , Caron Rigden , Leonel Hernandez-Aya , Lindsay Peterson , Mateusz Opyrchal , Katherine Clifton , Katherine Weilbaecher , Ron Bose , Cynthia Ma ,

, PS2-18-PS2-18, 2021-02-15

2 - Abstract PS17-06: A phase I trial of the PI3K inhibitor (PI3Ki) copanlisib and fulvestrant in combination with continuous or intermittent abemaciclib in patients with estrogen receptor-positive (ER+), HER2-negative (HER2-) metastatic breast cancer,Cancer Research

Cynthia Ma , Jingqin Luo , Jessica Moss , Maryann Kwa , Ritesh Parajuli , Katia Khoury , Emily Douglas , Ashley Frith , Caron Rigden , Foluso Ademuyiwa , Shana Thomas , Brittney Haas , Gerburg Wulf , Claire Dees , Rabih Said ,

, PS17-06-PS17-06, 2024-05-02

3 - Abstract OT2-03-01: RNA disruption assay (RDA) - Breast cancer response evaluation for individualized therapy (brevity/brevity-02),Cancer Research

Maureen Trudeau , Joke Tio , Foluso Ademuyiwa , Thierry Petit , Bryan Hennessy , Marina Cazzaniga , Daniele Generali ,

, OT2-03-01-OT2-03-01, 2022-02-15

4 - Abstract PD5-6: A phase I study of BKM120 and fulvestrant in postmenopausal women with estrogen receptor positive metastatic breast cancer,Cancer Research

Cynthia X Ma , Jingqin Luo , Michael Naughton , Foluso Ademuyiwa , Rama Suresh , Timothy Pluard , Gayathri Nagaraj , Kaitlin Arnold , Craig Lockhart , Matthew J Ellis ,

, PD5-6-PD5-6, 2015-05-01

5 - Abstract P3-06-06: Real-world analysis of adverse events of patients with triple negative breast cancer receiving therapy per KEYNOTE-522,Cancer Research

Mara Hofherr , Jennifer Hedgecorth , Foluso O. Ademuyiwa , Lindsay L. Peterson , Nusayba A. Bagegni , Rama Suresh , Ashley Frith , Ron Bose , Katherine Weilbaecher , Cynthia Ma , Andrew A. Davis , Katherine K. Clifton ,

, P3-06-06-P3-06-06, 2023-03-01

6 - Co-clinical FDG-PET Radiomic Signature in Predicting Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer,

Sudipta Roy , Timothy D. Whitehead , Shunqiang Li , Foluso O. Ademuyiwa , Richard L. Wahl , Farrokh Dehdashti , Kooresh I. Shoghi ,

, 2021-06-12

7 - Abstract PS18-07: Association between pathological response and tumor genomic profiling in triple negative breast cancer patients treated with neoadjuvant chemotherapy,Cancer Research

Foluso O Ademuyiwa , Jingqin Luo , Bryan Fisk , Gejae Jeffers , Tracy Summa , Isabella Grigsby , Mothaffar Rimawi , Meenakshi Anurag , Matthew Ellis , Obi Griffith , Malachi Griffith ,

, PS18-07-PS18-07, 2021-02-15

8 - Abstract 2420: Evaluating circulating tumor DNA (ctDNA) as a prognostic biomarker utilizing a tissue-free epigenomic assay in early-stage triple negative breast cancer (TNBC),Cancer Research

Foluso O. Ademuyiwa , Cynthia X. Ma , Katherine Weilbaecher , Rama Suresh , Lindsay Peterson , Ron Bose , Nusayba Bagegni , Caron E. Rigden , Ashley Frith , Katherine Clifton , Andrew Davis , Derek Dustin , Mingyang Cai ,

, 2420-2420, 2024-03-22

9 - Abstract P2-10-14: Racial differences in no-show rate for screening mammogram,Cancer Research

Whitney L Hensing , Steven Poplack , Cheryl Herman , Foluso O Ademuyiwa ,

, P2-10-14-P2-10-14, 2020-02-15

10 - Impact of American Society of Breast Surgeons (ASBS) guidelines on genetic testing (GT) rates among patients with breast cancer (BC).,Journal of Clinical Oncology

Shaili Tapiavala , Shireen Roy , Whitney L Hensing , Ying Liu , Foluso Olabisi Ademuyiwa , Amy E. Cyr ,

, e22537-e22537, 2024-06-01

11 - Abstract CT091: A neoadjuvant co-clinical trial in triple-negative breast cancer patients with genomic discovery analysis,Cancer Research

Foluso O. Ademuyiwa , Shunqiang Li , Jingqin Luo , Tracy Skinner , Jason Hoshower , Cynthia X. Ma , Katherine Weilbaecher , Michael Naughton , Leonel Hernandez-Aya , Elaine R. Mardis , Matthew J. Ellis ,

, CT091-CT091, 2016-07-15

12 - Patient-reported reasons for no-shows to screening mammogram appointments among African American women.,Journal of Clinical Oncology

Whitney L Hensing , Yu Tao , Chaelee Park , Dori Redding , Teresa Arb , Pechaz Clark , Stephanie White , Tess Thompson , Foluso Olabisi Ademuyiwa ,

, e18534-e18534, 2022-06-01

13 - Evaluating the acceptability, usability, and feasibility of a clinic-based genetic testing risk assessment intervention in Black women with breast cancer.,JCO Oncology Practice

Ashley J. Housten , Michelle Eggers , Amela Siječić , Erin Linnenbringer , Ana Baumann , Judy Johnson , Nedra Stevenson , Camille Neal , Foluso Olabisi Ademuyiwa ,

, 436-436, 2023-11-01

14 - Abstract P4-14-04: United States breast cancer mortality trends in young women according to race,Cancer Research

Foluso O Ademuyiwa , Feng Gao , Lin Hao , Daniel Morgensztern , Rebecca L Aft , Cynthia X Ma ,

, P4-14-04-P4-14-04, 2015-05-01

15 - Closing the gap: Trends in inconclusive rates on hereditary cancer testing across racial/ethnic groups.,Journal of Clinical Oncology

Foluso Olabisi Ademuyiwa , Carrie Horton , Holly LaDuca , Timothy Komala , Jessica Profato , Tina Pesaran , Fergus Couch ,

, 10525-10525, 2021-05-20

16 - Abstract P6-08-14: Assessing the effectiveness of the NCCN genetic testing guidelines in identifying African American breast cancer patients with deleterious genetic mutations,Cancer Research

Foluso O Ademuyiwa , Patricia Salyer , Yinjiao Ma , Sherri Fisher , Graham Colditz , Katherine Weilbaecher , Laura J Bierut ,

, P6-08-14-P6-08-14, 2020-02-15

Share Foluso's Profile